Treatment options for parasomnias

Area of Science:

• Sleep Medicine
• Neurology
• Psychiatry

Background:

• Parasomnias are disruptive sleep-related events.
• Current treatments include behavioral therapies and various medications.
• Limited high-quality evidence exists for many interventions.

Purpose of the Study:

• To review the current treatment landscape for parasomnias.
• To highlight the evidence base for different therapeutic approaches.
• To identify gaps in research regarding parasomnia treatments.

Main Methods:

• Review of existing literature on parasomnia treatments.
• Categorization of treatments into cognitive-behavioral therapy (CBT) and pharmacologic agents.
• Assessment of available evidence, focusing on randomized controlled trials.

Main Results:

• Cognitive-behavioral therapy (CBT) and pharmacologic agents are primary treatment modalities.
• Specific CBT techniques include cognitive restructuring and imagery rehearsal.
• Medications span various classes, including alpha-blockers, antidepressants, and benzodiazepines.
• Randomized trial data are robust only for CBT and prazosin in nightmares, and for enuresis therapies.

Conclusions:

• While diverse treatments exist for parasomnias, robust efficacy data from large-scale randomized trials are scarce for most.
• Further research, particularly large-scale randomized trials, is needed to establish the effectiveness of numerous parasomnia interventions.
• Current treatment decisions often rely on limited evidence, case reports, and clinical experience.